Metagenomi Therapeutics, Inc. (MGX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $574.0K | -81.6% |
| 2024 | $3.11M | -68.3% |
| 2023 | $9.81M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $574.0K | -81.6% |
| 2024 | $3.11M | -68.3% |
| 2023 | $9.81M | — |